Sort
15,273 grants matching “antimicrobial resistance”
Quantifying Microbial Keratitis to Predict Outcomes: An Imaging and Epidemiologic Approach
$397,264Maria Anneke Woodward · University Of Michigan At Ann Arbor · R01 · FY2022 · EY
Development of clinical decision tools for management of diarrhea of children in high and low resource settings
$397,159Daniel Ted Leung · University Of Utah · R01 · FY2020 · AI
The Role of ESCRT in Macrophage Resistance to Mycobacteria
$397,150Jennifer A Philips · New York University School Of Medicine · R01 · FY2013 · AI
Candidacidal Mechanisms of Salivary Histatins
$397,138Mira Edgerton · State University Of New York At Buffalo · R01 · FY2019 · DE
Trophoblast development and placental susceptibility to cytomegalovirus infection
$397,077Craig John Bierle · University Of Minnesota · R01 · FY2025 · HD
The evolution of copy number variations in the AT-rich Plasmodium genome
$397,040Jennifer Lynn Guler · University Of Virginia · R01 · FY2024 · AI
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
$397,034Kj Suda · University Of Illinois At Chicago · R01 · FY2017 · HS
Targeting cofactor biosynthesis in biodefense pathogens
$396,967Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2006 · AI
Cell-based screening and selection of cyclotide-based capture reagents for protei
$396,941Julio A Camarero · University Of Southern California · R01 · FY2012 · GM
Enhancing Collectin Mediated Defense Against Influenza
$396,913Kevan L Hartshorn · Boston Medical Center · R01 · FY2013 · HL
Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia (P-RAPP)
$396,882Todd Adam Florin · Lurie Children'S Hospital Of Chicago · R34 · FY2020 · HL
Plasma-initiated Cross-linked Nanocoatings asAnti-infection Agents
$396,836Christian Traba · Fairleigh Dickinson University · R01 · FY2024 · AI
In vitro and in silico investigations of changes in bacterial cell membrane dynamics due to polyunsaturated fatty acid (PUFA) modifications
$396,750David Giles · University Of Tennessee Chattanooga · R15 · FY2024 · GM
Role of AMP-activated protein kinase in bacterial endophthalmitis
$396,675Ashok Kumar · Wayne State University · R01 · FY2017 · EY
The evolution of copy number variations in the AT-rich Plasmodium genome
$396,638Jennifer Lynn Guler · University Of Virginia · R01 · FY2025 · AI
B-lactam mediated SOS response and expression of resistance in clinical MRSA
$396,610Adriana E Rosato · Methodist Hospital Research Institute · R01 · FY2014 · AI
Mathematical Modeling Core
$396,585Stephan Schmidt · University Of Florida · P01 · FY2019 · AI
Evaluating sexually transmitted infections among adolescent girls and young women within a pharmacy-based PrEP delivery model in Kenya.
$396,568Jillian Pintye · University Of Washington · R01 · FY2023 · HD
Biomimetic Peptide Aerosols for Rapid Clearance of Pulmonary MDR Tuberculosis
$396,522Scott Hammond Medina · Pennsylvania State University, The · R01 · FY2022 · AI
Mucosal Vaccines against Gonorrhea
$396,474Ann E. Jerse · Univ Of North Carolina Chapel Hill · U19 · FY2011 · AI
Eukaryotic-type signaling mediates two-component regulation of GBS virulence
$396,380Lakshmi Rajagopal · Seattle Children'S Hospital · R01 · FY2007 · AI
Antimicrobial effect of a new class of light resistant silver(I) complexes Adhesi
$396,264Nikolay Nikolaevich Gerasimchuk · Missouri State University · R15 · FY2012 · AI
Cytoskeletal Keratins in Epithelial Immunity to Bacterial Keratitis
$396,250K. P. Connie Tam · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · EY
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
$396,250Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
BETA LACTAMASE MUTATIONS IN ANTIBIOTIC RESISTANCE
$396,250Timothy Palzkill · Baylor College Of Medicine · R01 · FY2021 · AI